Cloud Pharmaceuticals

  • Have developed a proprietary algorithm combining artificial intelligence and quantum molecular dynamics to aid in designing new molecular drug structures for specified targets
  • Optimizes and ranks structures based on client-specified constraints such as solubility, active site binding, ease of m...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research

Molecular Quantum Solutions

Company Profile | May 26, 2021

Develops quantum chemistry simulation tools for a variety of use cases in chemistry R&D; currently, the company is focused on small molecule solubility prediction in preclinical pharmaceutical research, but its technology can also be applied to other use cases, such as protein‑ligand docking ... Not part of subscription


Company Snapshot | September 24, 2021

The company was founded by James Sas, Michelle Longmire, Perry Robinson, and Tim Smith in 2015. To date, the company has raised about $202.6 million over six rounds of funding, most recently raising a Series C round in April 2021. Among its investors, we emphasize Sapphire Ventures and GSR Ventures... Not part of subscription

Amalgam Rx

Company Profile | December 13, 2021

Amalgam Rx is a developer of a software‑as‑a‑service (SaaS)‑based technology platform that enables the development, deployment, and scaling of digital therapeutics and health service applications such as electronic health record (EHR) integration, clinical decision support, and clinical trial ... To read more, click here.